SAN FRANCISCO, November 22, 2018
A stem cell is a cell that holds an ability to provide new cells for the body as it nurtures and replace specific cells that are damage or lost. These cells are broadly categorized into human embryonic stem cells, adult Stem Cells, induced pluripotent stem cells, and very small embryonic like stem cells.
Stems cells can be developed in laboratory by taking a sample of adult cells such as blood cells or skin cells. For instance, the induced pluripotent stem cells (iPSCs) are developed in laboratory.
Effectiveness in Treating Diseases to Boost Demand
Stem cells finds application in regenerative Medicine and drug discovery and development. Regenerative medicines are Regenerative medicine is observed to have high potential to treat degenerative ailments and traumatic injury. These medicines can be applicable in different condition including oncology, orthopedics, neurology, cardiovascular and myocardial Infraction, hematology, incontinence, liver disorder, diabetes, injuries, and others. The neurology holds the largest revenue share due to accessibility of FDA approved products. On other hand, oncology segment is likely to exhibit fastest growth due to presence of strong pipeline of cancer therapies. Many research institutes and universities are also taking efforts towards the study and development of regenerative medicines. For instance, The University of Florida has recently introduced a Center for Regenerative Medicine for developing lifesaving therapies.
Also, Elevian, a new company developing medicines to treat and prevent age-related disease launches at TechCrunch Disrupt's Startup Battlefield. The company is currently focusing on conditions such as coronary artery disease, type2 diabetes, Sarcopenia (age-related muscle dysfunction), and Alzheimer's diseases.
Furthermore, use of stem cells in the development of novel drugs are expected to provide several new avenues for pharmaceutical companies. Developing trust of drug developing firms on cellular systems is expected to boost the drug discovery and development initiatives in the coming years.
Market Overview
According to a report published by Grand View Research, Inc.; the global stem cells market is expected to accomplish a valuation of around USD 15.63 billion by 2025. Increasing scope of these cells in clinical applications can drive the market during the forecast period (2014 to 2025). Technological advancements and growing research activities related to human stem cells is also expected to boost the market growth. Development of SCs for study of disease management is likely to increase the production of regenerative medicine. This is likely to support the market growth.
North America is expected to grow on account of existence of well-defined business models in the U.S. and Canada. On other hand, Asia Pacific is projected to display fastest growth over the forecast period.
Some of the leading companies operating in the stem cells market include Cellular Engineering Technologies Inc.; BrainStorm Cell Therapeutics; Bioheart Inc.; Advanced Cell Technology Inc.; and PromoCell GmbH.
No comments:
Post a Comment